Coya Therapeutics Posts $0.45 Net Loss Per Share in Third Quarter

John Kim

1 min read

Add as a preferred source on Google

Coya Therapeutics Posts $0.45 Net Loss Per Share in Third Quarter

Collaboration revenue was $234,134 for the quarter ended Sept. 30, 2026.

By John Kim

Published Nov 11, 2026, 8:58 AM EST

An unmarked steel oil barrel against a warm neutral backdrop / TokenPost.ai

Coya Therapeutics, Inc. recorded a net loss per share of $0.45 for the third quarter ended Sept. 30, 2026, while collaboration revenue totaled $234,134 for the same period.

The per-share loss was the same on a basic and diluted basis.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.